KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) FCF Margin (2016 - 2025)

Historic FCF Margin for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to 5.1%.

  • Medtronic's FCF Margin fell 14900.0% to 5.1% in Q4 2025 from the same period last year, while for Oct 2025 it was 14.98%, marking a year-over-year decrease of 16900.0%. This contributed to the annual value of 15.46% for FY2025, which is 6100.0% down from last year.
  • As of Q4 2025, Medtronic's FCF Margin stood at 5.1%, which was down 14900.0% from 6.81% recorded in Q3 2025.
  • Medtronic's 5-year FCF Margin high stood at 27.37% for Q2 2024, and its period low was 2.51% during Q4 2023.
  • In the last 5 years, Medtronic's FCF Margin had a median value of 16.39% in 2023 and averaged 15.55%.
  • As far as peak fluctuations go, Medtronic's FCF Margin skyrocketed by 123000bps in 2021, and later plummeted by -111900bps in 2022.
  • Over the past 5 years, Medtronic's FCF Margin (Quarter) stood at 19.09% in 2021, then tumbled by -59bps to 7.9% in 2022, then crashed by -68bps to 2.51% in 2023, then soared by 163bps to 6.59% in 2024, then dropped by -23bps to 5.1% in 2025.
  • Its last three reported values are 5.1% in Q4 2025, 6.81% for Q3 2025, and 23.18% during Q2 2025.